Jiangsu Hengrui reported CNY2.56B in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Kangmei Pharma CNY -12.72M 30.02M Mar/2026
Sh Fosun Pharma CNY 1.65B 88.09M Mar/2026
Sh Pharmaceutical CNY 5.01B 2.41B Jun/2025
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
WuXi AppTec CNY 7.98B 2.34B Jun/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 882.7M 351.1M Mar/2026